NAB2::STAT6 fusions and genome‐wide DNA methylation profiling: Predictors of patient outcomes in meningeal solitary fibrous tumors
Kathryn L. Eschbacher,Quynh T. Tran,Evgeny A. Moskalev,Sarah Jenkins,Karen Fritchie,Robert Stoehr,Alissa Caron,Michael J. Link,Paul D. Brown,Andrew Guajardo,Daniel J. Brat,Ashley Wu,Sandro Santagata,David N. Louis,Priscilla K. Brastianos,Alexander B. Kaplan,Brian Alexander,Sabrina Rossi,Fabio Ferrarese,David R. Raleigh,Minh P. Nguyen,John Gross,Jose Velazquez Vega,Fausto Rodriguez,Arie Perry,Maria Martinez‐Lage,Brent A. Orr,Florian Haller,Caterina Giannini
DOI: https://doi.org/10.1111/bpa.13256
IF: 7.611
2024-03-25
Brain Pathology
Abstract:Comprehensive molecular characterization of a cohort of 126 pathologically confirmed meningeal solitary fibrous tumors, including DNA methylation profiling, revealed the presence of three distinct methylation clusters: Cluster 1 (n = 38), Cluster 2 (n = 22), and Cluster 3 (n = 20). These methylation clusters were significantly associated with NAB2::STAT6 fusion breakpoints (fusion type), TERT promoter mutation status, histologic phenotype, and metastasis‐free survival. Meningeal solitary fibrous tumors (SFT) are rare and have a high frequency of local recurrence and distant metastasis. In a cohort of 126 patients (57 female, 69 male; mean age at surgery 53.0 years) with pathologically confirmed meningeal SFTs with extended clinical follow‐up (median 9.9 years; range 15 days–43 years), we performed extensive molecular characterization including genome‐wide DNA methylation profiling (n = 80) and targeted TERT promoter mutation testing (n = 98). Associations were examined with NAB2::STAT6 fusion status (n = 101 cases; 51 = ex5‐7::ex16‐17, 26 = ex4::ex2‐3; 12 = ex2‐3::exANY/other and 12 = no fusion) and placed in the context of 2021 Central Nervous System (CNS) WHO grade. NAB2::STAT6 fusion breakpoints (fusion type) were significantly associated with metastasis‐free survival (MFS) (p = 0.03) and, on multivariate analysis, disease‐specific survival (DSS) when adjusting for CNS WHO grade (p = 0.03). DNA methylation profiling revealed three distinct clusters: Cluster 1 (n = 38), Cluster 2 (n = 22), and Cluster 3 (n = 20). Methylation clusters were significantly associated with fusion type (p
pathology,neurosciences,clinical neurology